Why Healthcare Investors Should Focus on Growth-Stage Bets

Healthcare Venture Funding Takes a Nosedive in 2023

Healthcare venture funding experienced a steep decline in 2023, and later-stage startups were particularly affected. Many companies at the Series B or later stage struggled to justify their high valuations and had limited options for exits. As a result, some healthcare firms that traditionally backed growth-stage startups have switched their focus to seed and Series A deals. However, Dr. Galym Imanbayev, a partner at Lightspeed Venture Partners, plans to take advantage of this opportunity by targeting more growth-stage investments this year. He believes that there are still plenty of opportunities for later-stage healthcare startups to grow and succeed.